Dr. Mahad Discusses Protecting Nerve Cells in Progressive Multiple Sclerosis

Article

Don Mahad, MD, PhD, discusses his research's focus of protecting nerve cells at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston.

Don Mahad, MD, PhD, discusses his research’s focus of protecting nerve cells at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston.

Mahad shares his method of considering the role of mitochondrial damage as a springboard to identifying newer approaches to nerve protection.

“So I think trying different therapeutic options, targeting the neuronal pathways and mitochondria within you is a very exciting way of trying to solve the problem,” said Mahad.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.